Safer Attentuated Virus Vaccines with Missing or Diminished Latency of Infection
US Application 60/423,603
Filed on 2002-11-05
Filed on 2002-11-05
HTLV-1-Cell Binding & Inhibition
US Application 60/422,803
Filed on 2002-10-30
Filed on 2002-10-30
Non-Viral Mammalian Expression Vector
US Application 60/413,117
Filed on 2002-09-24
Filed on 2002-09-24
Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis
US Application 60/410,601
Filed on 2002-09-12
Filed on 2002-09-12
Lutzomyia Longipalpis polypeptides and methods of use
US Application 60/422,303
Filed on 2002-10-29
Filed on 2002-10-29
VAC-BAC Shuttle Vector System
US Application 60/402,824
Filed on 2002-08-09
Filed on 2002-08-09
METHODS FOR ASSESSING THE ABILITY OF HIV PATIENTS TO RESTRICT HIV REPLICATION
US Application 60/412,020
Filed on 2002-09-20
Filed on 2002-09-20
P. ARIASI POLYPEPTIDES AND P. PERNICIOSUS POLYPEPTIDES METHOD OF USE
US Application 60/412,327
Filed on 2002-09-19
Filed on 2002-09-19
MVA Expressing Modified HIV Envelope, Gag, and Pol Genes from HIV Subtype D
US Application 60/459,175
Filed on 2003-03-28
Filed on 2003-03-28